RESULTS
Of the 61 patients who received at least one dose of remdesivir, data from 8 could not be analyzed (including 7 patients with no post-treatment data and 1 with a dosing error). Of the 53 patients whose data were analyzed, 22 were in the United States, 22 in Europe or Canada, and 9 in Japan. At baseline, 30 patients (57%) were receiving mechanical ventilation and 4 (8%) were receiving extracorporeal membrane oxygenation. During a median follow-up of 18 days, 36 patients (68%) had an improvement in oxygen-support class, including 17 of 30 patients (57%) receiving mechanical ventilation who were extubated. A total of 25 patients (47%) were discharged, and 7 patients (13%) died; mortality was 18% (6 of 34) among patients receiving invasive ventilation and 5% (1 of 19) among those not receiving invasive ventilation. CONCLUSIONS
In this cohort of patients hospitalized for severe Covid-19 who were treated with compassionate-use remdesivir, clinical improvement was observed in 36 of 53 patients (68%). Measurement of efficacy will require ongoing randomized, placebo-controlled trials of remdesivir therapy. (Funded by Gilead Sciences.)
随便看看
- 【健康辟谣日历】运动后尿蛋白增多会加速肾病恶化?
- 【萧茗看世界】西方学者提出: 有证据显示新型冠状病毒在实验室合成 被泄漏
- 10月3日素香禅心厨艺班免费开班
- 哈佛和麻省理工发明可检测新冠病毒的口罩,只要呼吸就能显现出来
- 通报无症状感染者首日:18省份披露数据,仍有两百余例不知属地
- 脾虚肥胖的人:这4种食物越吃越虚,不要再吃了
- 人生有加法也有减法
- 病毒性心肌炎和感冒如何区分?记住这一点,或许能救你一命
- 远离心梗常因日常不良生活习惯突发,警惕十个“魔鬼时刻”远离它
- 疫情的秘密
- 导致你肥胖的真凶其实是它
- 可怕:法国变种病毒检测不出 且死亡率极高
- 女人供血不足易体寒,如何调理?
- 因新冠肺炎压力太大,纽约60名急救人员提前退休
- 收到Fed的$1200补助金居然犯法!留学生到底该不该拿补助
- 8张动图揭秘血管堵的全过程!建议每个人都看看